Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: Relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 12, 2013, Pages 2715-2723

  Camont, Laurent ^a,b,c,d   Lhomme, Marie ^a,b,c,d   Rached, Fabiana ^a,b,c,d,e   Le Goff, Wilfried ^a,b,c,d   Nègre Salvayre, Anne ^f,g   Salvayre, Robert ^f,g   Calzada, Catherine ^a   Lagarde, Michel ^a   Chapman, M John ^a,b,c,d   Kontush, Anatol ^a,b,c,d  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d IHU ICAN   (France)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f University Hospital of Toulouse   (France)

^g UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Functionality; HDL, small, dense; Lipidome; Lipidomics; Phosphatidylserine; Phospholipids; Sphingolipids

Indexed keywords

CERAMIDE; HIGH DENSITY LIPOPROTEIN 3; LYSOPHOSPHATIDYLCHOLINE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID; SPHINGOLIPID; SPHINGOMYELIN; THROMBOXANE B2;

ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL TRANSPORT; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MACROPHAGE; OXIDATIVE STRESS; PRIORITY JOURNAL; THROMBOCYTE; VASCULAR ENDOTHELIUM;

FUNCTIONALITY; HDL, SMALL, DENSE; LIPIDOME; LIPIDOMICS; PHOSPHATIDYLSERINE; PHOSPHOLIPIDS; SPHINGOLIPIDS;

ADULT; AGED; APOPTOSIS; ATHEROSCLEROSIS; BLOOD PLATELETS; CELL LINE, TUMOR; CERAMIDES; CHOLESTEROL; CHROMATOGRAPHY, LIQUID; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPROTEINS, HDL3; LIPOPROTEINS, LDL; MACROPHAGES; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; PARTICLE SIZE; PHOSPHOLIPIDS; SPHINGOLIPIDS; TANDEM MASS SPECTROMETRY; THROMBOSIS;

EID: 84888203299     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.113.301468     Document Type: Article

References (53)

1. Kontush A, Chapman MJ. High-Density Lipoproteins: Structure, Metabolism, Function and Therapeutics. New York: Wiley & Sons; 2012
2. Khera AV, Cuchel M, De La Llera-Moya M, Rodrigues A, Burke MF, Jafri K, French BC, Phillips JA, Mucksavage ML, Wilensky RL, Mohler ER, Rothblat GH, Rader DJ. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med. 2011;364:127-135
3. Ansell BJ, Navab M, Hama S, Kamranpour N, Fonarow G, Hough G, Rahmani S, Mottahedeh R, Dave R, Reddy ST, Fogelman AM. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation. 2003;108:2751-2756
4. de Souza JA, Vindis C, Hansel B, Nègre-Salvayre A, Therond P, Serrano CV Jr, Chantepie S, Salvayre R, Bruckert E, Chapman MJ, Kontush A. Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceriderich HDL3 particles with defective anti-Apoptotic activity. Atherosclerosis. 2008;197:84-94
5. Riwanto M, Rohrer L, Roschitzki B, Besler C, Mocharla P, Mueller M, Perisa D, Heinrich K, Altwegg L, von Eckardstein A, Lüscher TF, Landmesser U. Altered activation of endothelial anti-And proapoptotic pathways by highdensity lipoprotein from patients with coronary artery disease: Role of highdensity lipoprotein-proteome remodeling. Circulation. 2013;127:891-904
6. Camont L, Chapman MJ, Kontush A. Biological activities of HDL subpopulations and their relevance to cardiovascular disease. Trends Mol Med. 2011;17:594-603
7. Skipski VP, Barclay M, Barclay RK, Fetzer VA, Good JJ, Archibald FM. Lipid composition of human serum lipoproteins. Biochem J. 1967;104:340-352
8. Kontush A, Therond P, Zerrad A, Couturier M, Négre-Salvayre A, de Souza JA, Chantepie S, Chapman MJ. Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: Relevance to antiapoptotic and antioxidative activities. Arterioscler Thromb Vasc Biol. 2007;27:1843-1849
9. Wiesner P, Leidl K, Boettcher A, Schmitz G, Liebisch G. Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry. J Lipid Res. 2009;50:574-585
10. Scherer M, Böttcher A, Schmitz G, Liebisch G. Sphingolipid profiling of human plasma and FPLC-separated lipoprotein fractions by hydrophilic interaction chromatography tandem mass spectrometry. Biochim Biophys Acta. 2011;1811:68-75
11. Lee JY, Min HK, Choi D, Moon MH. Profiling of phospholipids in lipoproteins by multiplexed hollow fiber flow field-flow fractionation and nanoflow liquid chromatography-Tandem mass spectrometry. J Chromatogr A. 2010;1217:1660-1666
12. Deguchi H, Fernandez JA, Hackeng TM, Banka CL, Griffin JH. Cardiolipin is a normal component of human plasma lipoproteins. Proc Natl Acad Sci USA. 2000;97:1743-1748
13. Yetukuri L, Söderlund S, Koivuniemi A, Seppänen-Laakso T, Niemelä PS, Hyvönen M, Taskinen MR, Vattulainen I, Jauhiainen M, Oresic M. Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol. J Lipid Res. 2010;51:2341-2351
14. Davidson WS, Silva RA, Chantepie S, Lagor WR, Chapman MJ, Kontush A. Proteomic analysis of defined HDL subpopulations reveals particlespecific protein clusters: Relevance to antioxidative function. Arterioscler Thromb Vasc Biol. 2009;29:870-876
15. Huang R, Silva RA, Jerome WG, Kontush A, Chapman MJ, Curtiss LK, Hodges TJ, Davidson WS. Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma. Nat Struct Mol Biol. 2011;18:416-422
16. Silva RA, Huang R, Morris J, Fang J, Gracheva EO, Ren G, Kontush A, Jerome WG, Rye KA, Davidson WS. Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes. Proc Natl Acad Sci USA. 2008;105:12176-12181
17. Favari E, Calabresi L, Adorni MP, Jessup W, Simonelli S, Franceschini G, Bernini F. Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1. Biochemistry. 2009;48:11067-11074
18. Kontush A, Chantepie S, Chapman MJ. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler Thromb Vasc Biol. 2003;23:1881-1888
19. de Souza JA, Vindis C, Nègre-Salvayre A, Rye KA, Couturier M, Therond P, Chantepie S, Salvayre R, Chapman MJ, Kontush A. Small, dense HDL 3 particles attenuate apoptosis in endothelial cells: Pivotal role of apolipoprotein A-I. J Cell Mol Med. 2010;14:608-620
20. Quehenberger O, Dennis EA. The human plasma lipidome. N Engl J Med. 2011;365:1812-1823
21. Quehenberger O, Armando AM, Brown AH, et al. Lipidomics reveals a remarkable diversity of lipids in human plasma. J Lipid Res. 2010;51:3299-3305
22. Chapman MJ, Goldstein S, Lagrange D, Laplaud PM. A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. J Lipid Res. 1981;22:339-358
23. Zerrad-Saadi A, Therond P, Chantepie S, Couturier M, Rye KA, Chapman MJ, Kontush A. HDL3-mediated inactivation of LDL-Associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: Relevance to inflammation and atherogenesis. Arterioscler Thromb Vasc Biol. 2009;29:2169-2175
24. Larrede S, Quinn CM, Jessup W, Frisdal E, Olivier M, Hsieh V, Kim MJ, Van Eck M, Couvert P, Carrie A, Giral P, Chapman MJ, Guerin M, Le Goff W. Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independent. Arterioscler Thromb Vasc Biol. 2009;29:1930-1936
25. Navab M, Hama SY, Hough GP, Subbanagounder G, Reddy ST, Fogelman AM. A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. J Lipid Res. 2001;42:1308-1317
26. Jaspard B, Collet X, Barbaras R, Manent J, Vieu C, Parinaud J, Chap H, Perret B. Biochemical characterization of pre-beta 1 high-density lipoprotein from human ovarian follicular fluid: Evidence for the presence of a lipid core. Biochemistry. 1996;35:1352-1357
27. Hamon Y, Broccardo C, Chambenoit O, Luciani MF, Toti F, Chaslin S, Freyssinet JM, Devaux PF, McNeish J, Marguet D, Chimini G. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat Cell Biol. 2000;2:399-406
28. Fukuda M, Nakano M, Miyazaki M, Tanaka M, Saito H, Kobayashi S, Ueno M, Handa T. Conformational change of apolipoprotein A-I and HDL formation from model membranes under intracellular acidic conditions. J Lipid Res. 2008;49:2419-2426
29. Lecompte MF, Bras AC, Dousset N, Portas I, Salvayre R, Ayrault-Jarrier M. Binding steps of apolipoprotein A-I with phospholipid monolayers: Adsorption and penetration. Biochemistry. 1998;37:16165-16171
30. Rodrigueza WV, Thuahnai ST, Temel RE, Lund-Katz S, Phillips MC, Williams DL. Mechanism of scavenger receptor class B type I-mediated selective uptake of cholesteryl esters from high density lipoprotein to adrenal cells. J Biol Chem. 1999;274:20344-20350
31. Jang JH, Lee CS, Hwang D, Ryu SH. Understanding of the roles of phospholipase D and phosphatidic acid through their binding partners. Prog Lipid Res. 2012;51:71-81
32. Wan G, Zhaorigetu S, Liu Z, Kaini R, Jiang Z, Hu CA. Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death. J Biol Chem. 2008;283:21540-21549
33. Rao R, Albers JJ, Wolfbauer G, Pownall HJ. Molecular and macromolecular specificity of human plasma phospholipid transfer protein. Biochemistry. 1997;36:3645-3653
34. Chen S, Subbaiah PV. Phospholipid and fatty acid specificity of endothelial lipase: Potential role of the enzyme in the delivery of docosahexaenoic acid (DHA) to tissues. Biochim Biophys Acta. 2007;1771:1319-1328
35. Rosenson RS, Brewer HB Jr, Chapman MJ, Fazio S, Hussain MM, Kontush A, Krauss RM, Otvos JD, Remaley AT, Schaefer EJ. HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events. Clin Chem. 2011;57:392-410
36. Nilsson A, Duan RD. Absorption and lipoprotein transport of sphingomyelin. J Lipid Res. 2006;47:154-171
37. Duong PT, Collins HL, Nickel M, Lund-Katz S, Rothblat GH, Phillips MC. Characterization of nascent HDL particles and microparticles formed by ABCA1-mediated efflux of cellular lipids to apoA-I. J Lipid Res. 2006;47:832-843
38. Yancey PG, De La Llera-Moya M, Swarnakar S, Monzo P, Klein SM, Connelly MA, Johnson WJ, Williams DL, Rothblat GH. High density lipoprotein phospholipid composition is a major determinant of the bidirectional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI. J Biol Chem. 2000;275:36596-36604
39. Zhao Y, Sparks DL, Marcel YL. Effect of the apolipoprotein A-I and surface lipid composition of reconstituted discoidal HDL on cholesterol efflux from cultured fibroblasts. Biochemistry. 1996;35:16510-16518
40. Hara S, Shike T, Takasu N, Mizui T. Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells. Arterioscler Thromb Vasc Biol. 1997;17:1258-1266
41. Rosenblat M, Vaya J, Shih D, Aviram M. Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: A possible role for lysophosphatidylcholine. Atherosclerosis. 2005;179:69-77
42. Aslanian AM, Charo IF. Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis. Circulation. 2006;114:583-590
43. Yancey PG, Kawashiri MA, Moore R, Glick JM, Williams DL, Connelly MA, Rader DJ, Rothblat GH. In vivo modulation of HDL phospholipids has opposing effects on SR-BI-And ABCA1-mediated cholesterol efflux. J Lipid Res. 2004;45:337-346
44. Haidar B, Mott S, Boucher B, Lee CY, Marcil M, Genest J Jr. Cellular cholesterol efflux is modulated by phospholipid-derived signaling molecules in familial HDL deficiency/Tangier disease fibroblasts. J Lipid Res. 2001;42:249-257
45. Davidson WS, Gillotte KL, Lund-Katz S, Johnson WJ, Rothblat GH, Phillips MC. The effect of high density lipoprotein phospholipid acyl chain composition on the efflux of cellular free cholesterol. J Biol Chem. 1995;270:5882-5890
46. Marmillot P, Patel S, Lakshman MR. Reverse cholesterol transport is regulated by varying fatty acyl chain saturation and sphingomyelin content in reconstituted high-density lipoproteins. Metabolism. 2007;56:251-259
47. Baker PW, Rye KA, Gamble JR, Vadas MA, Barter PJ. Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression. J Lipid Res. 2000;41:1261-1267
48. Kimura T, Sato K, Kuwabara A, Tomura H, Ishiwara M, Kobayashi I, Ui M, Okajima F. Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells. J Biol Chem. 2001;276:31780-31785
49. Nofer JR, Assmann G. Atheroprotective effects of high-density lipoprotein-Associated lysosphingolipids. Trends Cardiovasc Med. 2005;15: 265-271
50. Taha TA, Mullen TD, Obeid LM. A house divided: Ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death. Biochim Biophys Acta. 2006;1758:2027-2036
51. Brodde MF, Korporaal SJ, Herminghaus G, Fobker M, Van Berkel TJ, Tietge UJ, Robenek H, Van Eck M, Kehrel BE, Nofer JR. Native highdensity lipoproteins inhibit platelet activation via scavenger receptor BI: Role of negatively charged phospholipids. Atherosclerosis. 2011;215: 374-382
52. Davidson WS, Sparks DL, Lund-Katz S, Phillips MC. The molecular basis for the difference in charge between pre-beta-And alpha-migrating high density lipoproteins. J Biol Chem. 1994;269:8959-8965
53. Boucher JG, Nguyen T, Sparks DL. Lipoprotein electrostatic properties regulate hepatic lipase association and activity. Biochem Cell Biol. 2007;85:696-708